Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Glomerulosclerosis, Focal Segmental; Recurrence Phase 2 ClinicalTrials
Leukemia; Leukemia, Lymphoid; Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase 1/Phase 2 ClinicalTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase 2 ClinicalTrials
Arthritis; Arthritis, Rheumatoid Phase 2 ClinicalTrials
CONTENTS